Our first in the first family of tailored solutions for the Drug Product sector: the EVE particle counter.
The revolutionary analytical testing device, supported with single-use consumables, maintenance and training services, for the biotechs drug product sector is based on a new combination light obscuration technology and smart automation.
Different to the existing technologies Bionter's PC100 works non-destructive. i.e. it requires smaller sample volume which can be used for other testing thus reducing costs. Its smart automation workflow drives efficiency and minimizes human interaction and therefore improves reliability, data integrity and in turn patient safety. It also stays compliant to current regulatory requirements offering a low product entrance barrier.
The revolutionary analytical testing device, supported with single-use consumables, maintenance and training services, for the biotechs drug product sector is based on a new combination light obscuration technology and smart automation.
Different to the existing technologies Bionter's PC100 works non-destructive. i.e. it requires smaller sample volume which can be used for other testing thus reducing costs. Its smart automation workflow drives efficiency and minimizes human interaction and therefore improves reliability, data integrity and in turn patient safety. It also stays compliant to current regulatory requirements offering a low product entrance barrier.
Location: Switzerland, Basel-City, Riehen
Total raised: $3M
Investors 2
| Date | Name | Website |
| - | Venture Ki... | venturekic... |
| 09.11.2022 | VentureLab | venturelab... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.04.2022 | Seed | $3M | Dynamk Cap... |
Mentions in press and media 11
| Date | Title | Description |
| 28.09.2022 | Israeli-Swiss Lean Launchpad Program 2022 supports eight startups | |
| 21.07.2022 | Ten Biotech startups brace for Boston | |
| 29.06.2022 | Enerdrape wins the Grand Prize at the 25th >>venture>> edition | |
| 23.05.2022 | >>venture>> announces 15 winners | |
| 28.04.2022 | Bionter Raises $3M in Seed Funding | Bionter, a Riehen, Switzerland based provider of sub-visible particle testing solutions, raised $3M in Seed funding. The round was led by Dynamk Capital. The company intends to use the funds to expand their team, launch their first solution... |
| 28.04.2022 | Medtech startup Bionter secures $3 million seed financing | |
| 27.04.2022 | Bionter AG secures $3 Million in Series Seed Financing Led by Dynamk Capital | April 27, 2022, Riehen, Switzerland - Bionter AG, experts in sub-visible particle testing, announced the completion of a $3 million Series Seed financing from Dynamk Capital. Bionter revolutionizes analytical testing of subvisible particles... |
| 20.08.2021 | CHF 40,000 for startups empowering retailers with AI, revolutionizing analytical testing for health and monitoring machine incidents | AI Retailer Systems: Empowering retailers to checkout-free convenience Offline retail, a EUR 12 trillion market, is losing share as shoppers increasingly go online, more so post-COVID-19. Clearly, shoppers appreciate “anytime and anyplace” ... |
| 20.08.2021 | CHF 40,000 for startups empowering retailers with AI, revolutionizing analytical testing for health and monitoring machine incidents | AI Retailer Systems: Empowering retailers to checkout-free convenience Convenience retailers address on-demand consumer needs for food & grocery (330 Bil. CHF market in DACH). Running convenience stores the conventional way come at high... |
| 20.08.2021 | CHF 40,000 for startups revolutionizing analytical testing for health and monitoring machine incidents | Bionter: Revolutionizing analytical testing to improve people’s health Many liquid drugs contain particles that are critical for patient safety. Sub-visible particle testing is mandatory for any biopharmaceutical preparation during stabilit... |
Show more